TrialCancer immunology, immunotherapy : CII2025

Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab.

Xuefeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.